story of the week
Acalabrutinib vs Ibrutinib in Previously Treated CLL
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia: Results of the First Randomized Phase III Trial
J. Clin. Oncol 2021 Jul 26;[EPub Ahead of Print], JC Byrd, P Hillmen, P Ghia, AP Kater, A Chanan-Khan, RR Furman, S O'Brien, MN Yenerel, A Illés, N Kay, JA Garcia-Marco, A Mato, J Pinilla-Ibarz, JF Seymour, S Lepretre, S Stilgenbauer, T Robak, W Rothbaum, R Izumi, A Hamdy, P Patel, K Higgins, S Sohoni, W JurczakFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.